HOUSTON--(BUSINESS WIRE)--CytoGenix (OTCBB:CYGX) has demonstrated that a synDNA™
vaccine against human immunodeficiency virus (HIV) has activity in
monkeys. The study, conducted...
HOUSTON--(BUSINESS WIRE)--CytoGenix (OTCBB:CYGX) has demonstrated that a synDNA™
vaccine against human immunodeficiency virus (HIV) has activity in
monkeys. The study, conducted...
HOUSTON--(BUSINESS WIRE)--CytoGenix, Inc. (OTCBB:CYGX) announces that Pamela Schertz has
been appointed as interim Chief Financial Officer. Ms. Schertz has
served the Company as...
HOUSTON--(BUSINESS WIRE)--CytoGenix, Inc. (OTCBB:CYGX) announces the conclusion of
negotiations with GSL Constructors, Ltd for the design/build development
of a $3.8 million, 20,000...
HOUSTON--(BUSINESS WIRE)--CytoGenix, Inc. (CYGX:OB) has received notices of allowances for
grant of patent applications covering the technology for expressing
ssDNA In Vivo, from the...
HOUSTON--(BUSINESS WIRE)--Aug. 31, 2006--CytoGenix, Inc. (OTCBB:CYGX) announced today that its Vice President and Chief Scientific Officer, Dr. Yin Chen and Senior Scientist, Dr. Xin-Xing Tan were...
HOUSTON--(BUSINESS WIRE)--Aug. 30, 2006--CytoGenix, Inc. (OTCBB:CYGX) announced today that its President Chairman and CEO, Dr. Malcolm Skolnick, is a featured speaker at the Life Sciences...
HOUSTON--(BUSINESS WIRE)--Aug. 24, 2006--CytoGenix, Inc. (OTCBB:CYGX) announced today that it has filed a patent application entitled "Single Stranded Expression Systems for Cancer Genetics and...
HOUSTON--(BUSINESS WIRE)--July 25, 2006--CytoGenix, Inc. (OTCBB:CYGX) has received allowance for the patent application No. 00815856.8 entitled "Altering Gene Expression with ssDNA Produced In...
HOUSTON--(BUSINESS WIRE)--June 29, 2006--CytoGenix, Inc. (OTCBB:CYGX) Frost & Sullivan, the leading global growth consulting company has chosen CytoGenix as the recipient of the 2006 Technology...
HOUSTON--(BUSINESS WIRE)--Dec. 30, 2005--CytoGenix, Inc. (OTCBB:CYGX) announced today the successful completion of a genetic immunization animal trial using a synDNA(TM) vaccine against an H1N1...
HOUSTON--(BUSINESS WIRE)--Dec. 27, 2005--CytoGenix, Inc. (OTCBB:CYGX) announced today the signing of a contract with the Fast Trak BioDefense group of GE Healthcare, a unit of General Electric...